Toronto Faculty Studies LDLT as Novel Treatment for Liver Cancer

May 13, 2019

Dr. Gonzalo Sapisochin

Surgeons at Toronto General Hospital have begun a research study to determine if living donor liver transplantation is an effective treatment for colorectal cancer which has spread to the liver.

The first patient in this study, who has chosen to remain anonymous, underwent chemotherapy treatment, followed by a living donor liver transplant.  Both the donor and recipient are doing well two months after transplantation.

The innovative study hopes to recruit about 20 patients with colorectal cancer which has spread to the liver, who are being treated with chemotherapy. Their cancer must be stable, and not growing, and they cannot be candidates for liver cancer surgery. Patients must have someone willing to be a living liver donor.

Please read more on UHN News: